Scynexis (SCYX) Gross Profit (QoQ) (2013 - 2024)
Scynexis (SCYX) Gross Profit (QoQ) (2013 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.51 Bn | 87.64 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.95 Bn | 32.21 Bn | 1.97 Bn |
| 3 | Zoetis | 32.59 Bn | 30.65 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.51 Bn | 23.45 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.06 Bn | 20.91 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - |
| 7 | Viatris | 20.25 Bn | 18.44 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.48 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Scynexis | 23.44 Mn | -13.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 48.03% |
| Sep 30, 2024 | -10.33% |
| Jun 30, 2024 | -46.39% |
| Mar 31, 2024 | 115.45% |
| Dec 31, 2023 | -743.05% |
| Sep 30, 2023 | -98.95% |
| Jun 30, 2023 | 13,095.17% |
| Mar 31, 2023 | -25.23% |
| Dec 31, 2022 | -2.92% |
| Sep 30, 2022 | 16.03% |
| Jun 30, 2022 | 96.17% |
| Mar 31, 2022 | 39.77% |
| Dec 31, 2021 | 15.90% |
| Mar 31, 2015 | -96.00% |
| Dec 31, 2014 | 129.31% |
| Sep 30, 2014 | 55.84% |
| Jun 30, 2014 | -37.99% |
| Mar 31, 2014 | 837.62% |
| Dec 31, 2013 | -157.06% |
| Sep 30, 2013 | 203.51% |